Bio-Works signs a new SEK 2.8m US deal
The partnership focuses on purifying biological medicines for an unnamed global biotechnology firm and may expand as drug development advances.
See the latest news and media coverage for Bio-Works. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of chromatography resins for biopharmaceutical purification
bio-works.comLast updated
In short: Bio-Works reported a 53% increase in Q2 2026 net sales and appointed Eva Lindskog as its new CEO starting in November.
The partnership focuses on purifying biological medicines for an unnamed global biotechnology firm and may expand as drug development advances.
Net sales rose to 20 million SEK while operating profit improved and a new CEO appointment is planned for November.
Net sales rose 53 percent to 20.0 MSEK, while operating losses narrowed significantly compared to the prior year.
Lindskog assumes the position on November 1, 2026, and replaces Lone Carlbom, who returns to an operational role.
Close LIVE: Report Morning July 17. Bio-Works has received a new order from a recurring customer with an order value of SEK 22.6 million. SEHED Byggmästargruppen takes...
HOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE)-- BIO-key International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies...
TG4050 is an individualized immunotherapy based on an MVA viral vector incorporating neoantigens selected using NEC's AI-enabled prediction platform. It is currently being evaluated in...
Bio-Works Technologies' annual general meeting was held on 15 May 2025. In her address to the Annual General Meeting, CEO Lone Carlbom provided a summary...
Track Bio-Works and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bio-Works and other trending companies.